JNCCN-360

Editor:

David S. Ettinger, MD

Advertisement

Advertisement

Jessica S. Donington, MD, on Treating Early-Stage Thoracic Cancers

Shirish M. Gadgeel, MD, on Advanced Non–Small Cell Lung Cancer: Integrating Chemotherapy and Immunotherapy

Matthew A. Gubens, MD, on Non–Small Cell Lung Cancer: Is There Still a Role for Chemotherapy?

Recent

AACR 2019: Savolitinib Plus Osimertinib in EGFR -Mutant, MET-Amplified NSCLC

ELCC 2019: Pembrolizumab Monotherapy in Elderly Patients With Advanced NSCLC

HOPA 2019: Flat-Dose Nivolumab Dosing in First-Line Treatment of NSCLC

FDA Expands Pembrolizumab Indication in First-Line Treatment of NSCLC

Published

Medical Literature

Stereotactic Ablative Radiotherapy for Inoperable Early-Stage Lung Cancer

Does Prophylactic Cranial Irradiation Extend Survival in Locally Advanced Lung Cancer?

Shared Decision-Making in Lung Cancer Treatment: Patient Priorities and Preferences

Can MET Copy Number Predict TKI Resistance in EGFR -Mutant NSCLC?

Ongoing

Proceedings from the 15th Annual Winter Lung Cancer Conference

Advanced Non-Small Cell Lung Ccancer Patient Management Simulator

An Advanced Practitioner’s Guide to Cell Signaling Pathways in NSCLC

Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care-Lung Cancer: Advanced Disease

Available

Clinical Trials

UCSF Helen Diller Family Comprehensive Cancer Center

The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute

Fred and Pamela Buffett Cancer Center

Fox Chase Cancer Center

NCCN Resources

Copyright © 2019 National Comprehensive Cancer Network, All Rights Reserved

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.